pharma sector

The overall under-performance of the US business vis-a-vis other businesses is likely to continue in the absence of any fresh triggers. Improving R&D investments and increasing…
Read More...

NEW DELHI: Dr Reddy's Laboratories () is likely to report a 25 per cent year-on-year (YoY) rise in net profit at Rs 710 crore, as per an ET NOW poll of analysts. The drugmaker had…
Read More...